US8609622, 1

ID: ALA3689507

Chembl Id: CHEMBL3689507

PubChem CID: 56832737

Max Phase: Preclinical

Molecular Formula: C25H29ClO8

Molecular Weight: 492.95

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OC[C@]12CO[C@](c3ccc(Cl)c(Cc4ccc(OCCOC5CC5)cc4)c3)(O1)[C@H](O)[C@@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C25H29ClO8/c26-20-8-3-17(25-23(30)21(28)22(29)24(13-27,34-25)14-33-25)12-16(20)11-15-1-4-18(5-2-15)31-9-10-32-19-6-7-19/h1-5,8,12,19,21-23,27-30H,6-7,9-11,13-14H2/t21-,22-,23+,24+,25+/m0/s1

Standard InChI Key:  VCZVXZUEEYJYLC-UBCNIHEASA-N

Associated Targets(non-human)

Slc5a2 Sodium/glucose cotransporter 2 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc5a1 SGLT1 protein (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 492.95Molecular Weight (Monoisotopic): 492.1551AlogP: 1.52#Rotatable Bonds: 9
Polar Surface Area: 117.84Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.98CX Basic pKa: CX LogP: 2.38CX LogD: 2.38
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.39Np Likeness Score: 0.74

References

1.  (2013)  C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof, 

Source

Source(1):